• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies.

作者信息

Korkes Fernando, Maluf Fernando

机构信息

Disciplina de Urologia, Faculdade de Medicina do ABC, Santo André, SP, Brasil.

Departamento de Urologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.

出版信息

Int Braz J Urol. 2021 Mar-Apr;47(2):443-447. doi: 10.1590/S1677-5538.IBJU.2020.0658.

DOI:10.1590/S1677-5538.IBJU.2020.0658
PMID:33284548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857771/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7857771/57f3654ba55e/1677-6119-ibju-47-02-0443-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7857771/8cd8716d49d1/1677-6119-ibju-47-02-0443-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7857771/57f3654ba55e/1677-6119-ibju-47-02-0443-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7857771/8cd8716d49d1/1677-6119-ibju-47-02-0443-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7857771/57f3654ba55e/1677-6119-ibju-47-02-0443-gf02.jpg

相似文献

1
Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies.巴西卫生系统中膀胱癌成本的不断增加：制定公共卫生政策的作用。
Int Braz J Urol. 2021 Mar-Apr;47(2):443-447. doi: 10.1590/S1677-5538.IBJU.2020.0658.
2
[Contradictions of public health policies geared to rare disorders: the example of the Osteogenesis Imperfecta Treatment Program in the Brazilian Unified Health System (SUS)].[面向罕见病的公共卫生政策矛盾：以巴西统一卫生系统（SUS）中的成骨不全治疗项目为例]
Cien Saude Colet. 2014 Feb;19(2):475-80. doi: 10.1590/1413-81232014192.15582012.
3
[The Brazilian experience with tobacco control policies].[巴西烟草控制政策的经验]
Salud Publica Mex. 2004 Nov-Dec;46(6):549-58. doi: 10.1590/s0036-36342004000600011.
4
Vaccine research, development, and innovation in Brazil: a translational science perspective.巴西的疫苗研究、开发和创新：转化科学视角。
Vaccine. 2013 Apr 18;31 Suppl 2:B54-60. doi: 10.1016/j.vaccine.2012.11.084.
5
Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine.从巴西公共卫生系统角度来看登革热疾病 16 年来的经济和流行病学影响，为未来的卫生政策提供信息，包括采用登革热疫苗。
Expert Rev Vaccines. 2018 Dec;17(12):1123-1133. doi: 10.1080/14760584.2018.1546581.
6
[The role of states in mental health policy in Brazil].[巴西各州在心理健康政策中的作用]
Cad Saude Publica. 2011 Nov;27(11):2227-41. doi: 10.1590/s0102-311x2011001100016.
7
[Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].[巴西卫生部在将技术纳入巴西统一国家卫生系统的决策过程中对卫生技术评估的运用]
Cad Saude Publica. 2013 Nov;29 Suppl 1:S7-16. doi: 10.1590/0102-311x00008413.
8
Bridging the gap between science and public health: taking advantage of tobacco control experience in Brazil to inform policies to counter risk factors for non-communicable diseases.弥合科学与公共卫生之间的差距：利用巴西在烟草控制方面的经验为制定针对非传染性疾病风险因素的政策提供信息。
Addiction. 2013 Aug;108(8):1360-6. doi: 10.1111/add.12203. Epub 2013 May 7.
9
The first 30 years of the SUS: an uncomfortable balance?统一卫生系统的头30年：一种令人不安的平衡？
Cien Saude Colet. 2018 Jun;23(6):2043-2050. doi: 10.1590/1413-81232018236.06082018.
10
Constructing public oral health policies in Brazil: issues for reflection.构建巴西公共口腔卫生政策：值得思考的问题。
Braz Oral Res. 2012;26 Suppl 1:94-102. doi: 10.1590/s1806-83242012000700014.

引用本文的文献

1
Challenges and opportunities in NMIBC management across Latin America: insights from healthcare providers and a patient advocacy group.拉丁美洲非肌层浸润性膀胱癌管理中的挑战与机遇：来自医疗服务提供者和患者倡导组织的见解
Ecancermedicalscience. 2024 Jun 7;18:1711. doi: 10.3332/ecancer.2024.1711. eCollection 2024.
2
Microscopic hematuria and pelvic ultrasonography could rule out flexible cystoscopy during surveillance for T1-low grade non-muscle invasive bladder cancer.在T1期低级别非肌层浸润性膀胱癌监测期间，显微镜下血尿检查和盆腔超声检查可排除软性膀胱镜检查。
Arab J Urol. 2023 Apr 17;21(3):150-155. doi: 10.1080/2090598X.2023.2202930. eCollection 2023.
3

本文引用的文献

1
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南：2020 年指南摘要。
Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29.
2
Bladder cancer trends and mortality in the brazilian public health system.巴西公共卫生系统中的膀胱癌趋势和死亡率。
Int Braz J Urol. 2020 Mar-Apr;46(2):224-233. doi: 10.1590/S1677-5538.IBJU.2019.0198.
3
Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.
Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.
巴西人群中高级别肌层浸润性尿路上皮膀胱癌成纤维细胞生长因子受体3基因（FGFR3）突变：评估与患病率
Einstein (Sao Paulo). 2022 Apr 1;20:eAO6450. doi: 10.31744/einstein_journal/2022AO6450. eCollection 2022.
4
VI-RADS score system - A primer for urologists.VI-RADS 评分系统——泌尿科医师入门。
Int Braz J Urol. 2022 Jul-Aug;48(4):609-622. doi: 10.1590/S1677-5538.IBJU.2021.0560.
5
Stage-Related Cost of Treatment of Bladder Cancer in Brazil.巴西膀胱癌治疗的分期相关费用。
Pharmacoecon Open. 2022 May;6(3):461-468. doi: 10.1007/s41669-022-00325-7. Epub 2022 Feb 14.
6
Challenging dilemmas of low grade, non-invasive bladder cancer: a narrative review.低级别、非浸润性膀胱癌的困境：叙述性综述。
Int Braz J Urol. 2022 May-Jun;48(3):397-405. doi: 10.1590/S1677-5538.IBJU.2021.0259.
7
Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer.卡介苗（BCG）在膀胱癌治疗中的巴西幕后故事
Int Braz J Urol. 2021 Mar-Apr;47(2):232-236. doi: 10.1590/S1677-5538.IBJU.2021.02.02.
肌层浸润性膀胱癌的膀胱保留治疗：全面综述。
Int Braz J Urol. 2020 Mar-Apr;46(2):169-184. doi: 10.1590/S1677-5538.IBJU.2020.99.01.
4
High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients.根治性膀胱切除术后死亡率高：我们必须有可接受的方案，并考虑为高危患者实施皮肤输尿管造口术的基本原理。
Int Braz J Urol. 2019 Nov-Dec;45(6):1090-1093. doi: 10.1590/S1677-5538.IBJU.2019.05.03.
5
Legal access to medications: a threat to Brazil's public health system?药品的合法获取：对巴西公共卫生系统的威胁？
BMC Health Serv Res. 2017 Jul 19;17(1):499. doi: 10.1186/s12913-017-2430-x.
6
Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.自《改善预后指南》发布十年后，英国膀胱癌根治性膀胱切除术的集中化：超级集中化的理由。
BJU Int. 2018 Feb;121(2):217-224. doi: 10.1111/bju.13929. Epub 2017 Jul 10.
7
Are we following the guidelines on non-muscle invasive bladder cancer?我们是否遵循了非肌肉浸润性膀胱癌的指南？
Int Braz J Urol. 2016 Jan-Feb;42(1):22-8. doi: 10.1590/S1677-5538.IBJU.2015.0122.
8
Bladder cancer: a disease ripe for major advances.膀胱癌：一种亟待取得重大进展的疾病。
Clin Adv Hematol Oncol. 2014 Dec;12(12):838-45.
9
Economic aspects of bladder cancer: what are the benefits and costs?膀胱癌的经济层面：益处与成本分别是什么？
World J Urol. 2009 Jun;27(3):295-300. doi: 10.1007/s00345-009-0395-z. Epub 2009 Mar 7.